Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (82,771)	$ (100,018)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	8,543	8,736
Stock-based compensation	94,113	108,176
Amortization of deferred commissions	19,906	17,547
Non-cash operating lease costs	7,050	7,087
Amortization of debt issuance costs	1,264	1,133
Amortization of premium and accretion of discount on marketable securities	(11,288)	(5,557)
Acquired in-process research and development	6,653	0
Changes in assets and liabilities:
Trade receivables	49,913	24,895
Prepaid expenses and other short-term assets	(10,889)	(11,118)
Deferred commissions	(23,846)	(18,338)
Other long-term assets	(129)	(963)
Trade payables	817	(1,634)
Accrued expenses and other short-term liabilities	(5,882)	(17,652)
Deferred revenues	37,200	33,555
Other long-term liabilities	272	3,120
Net cash provided by operating activities	90,926	48,969
Cash flows from investing activities:
Proceeds from maturities of marketable securities	157,100	28,850
Investment in marketable securities	(576,753)	(331,651)
Proceeds from short-term and long-term deposits	25,038	170,925
Investment in short-term and long-term deposits	(9,233)	(118,605)
Purchase of in-process research and development	(6,653)	0
Purchases of property and equipment	(2,342)	(2,945)
Net cash used in investing activities	(412,843)	(253,426)
Cash flows from financing activities:
Proceeds from issuance of convertible senior notes, net of issuance costs	450,099	0
Purchases of capped calls	(55,522)	0
Proceeds from employee stock plans	16,082	11,346
Taxes paid related to net share settlement of equity awards	(37,264)	(19,971)
Repurchase of common stock	0	(43,522)
Net cash provided by (used in) financing activities	373,395	(52,147)
Increase (decrease) in cash and cash equivalents	51,478	(256,604)
Cash and cash equivalents at beginning of period	230,740	367,800
Cash and cash equivalents at end of period	282,218	111,196
Supplemental disclosure of cash flow information:
Cash paid for income taxes	10,115	6,231
Cash paid for interest	3,184	3,195
Supplemental disclosure of non-cash activities:
Lease liabilities arising from obtaining right-of-use assets	573	1,945
Issuance of common stock for debt conversion	6	0
Issuance costs included in accrued expenses and other short-term liabilities	$ 450	$ 0